Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia

Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV–specific neut...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Abeer N. Alshukairi, Jincun Zhao, Maha A. Al-Mozaini, Yanqun Wang, Ashraf Dada, Salim A. Baharoon, Sara Alfaraj, Waleed A. Ahmed, Mushira A. Enani, Fatehi E. Elzein, Nazik Eltayeb, Laila Layqah, Aiman El-Saed, Husam A. Bahaudden, Abdul Haseeb, Sherif A. El-Kafrawy, Ahmed M. Hassan, Najlaa A. Siddiq, Ibtihaj Alsharif, Isamel Qushmaq, Esam I. Azhar, Stanley Perlman, Ziad A. Memish
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Centers for Disease Control and Prevention 2021-05-01
Sarja:	Emerging Infectious Diseases
Aiheet:	Middle East respiratory syndrome coronavirus MERS-CoV coronaviruses viruses Middle East respiratory syndrome MERS
Linkit:	https://wwwnc.cdc.gov/eid/article/27/5/20-4056_article
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!